Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neuroblastoma: a multiple biological disease

¹Department of Hematology and Oncology, G. Gaslini Children's Hospital, Genova, Italy.

European Journal of Cancer (Oxford, England : 1990)

|January 1, 1993

Summary

Neuroblastoma (NB) exhibits diverse clinical behaviors, with distinct genetic alterations differentiating localized from metastatic tumors. Advanced NB follows a multistep cancer development model, while stage 4S NB presents unique characteristics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells.

Oncogene·2023

Same author

Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.

BMC cancer·2019

Same author

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

British journal of cancer·2014

Same author

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

British journal of cancer·2012

Same author

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

British journal of cancer·2011

Same author

Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

Cellular oncology (Dordrecht, Netherlands)·2011

Area of Science:

Paediatric oncology
Cancer genetics
Tumour biology

Background:

Neuroblastoma (NB) presents significant variability in clinical outcomes, ranging from localized, treatable tumors to aggressive metastatic disease.
This clinical heterogeneity suggests underlying biological diversity and distinct genetic profiles between different NB stages.

Purpose of the Study:

To investigate the molecular and genetic differences in neuroblastoma based on clinical stage and metastatic potential.
To understand the distinct biological pathways driving advanced versus infant metastatic (4S) neuroblastoma.

Main Methods:

Analysis of genetic abnormalities including loss of heterozygosity for chromosome 1p and MYCN amplification.
Comparison of genetic profiles across localized (stages 1-2) and metastatic (stages 3-4) neuroblastoma, including stage 4S.

Main Results:

Specific genetic alterations like 1p deletion and MYCN amplification are prevalent in advanced stages (3-4) but rare in early stages (1-2).
Metastatic stage 4S neuroblastoma in infants displays unique genetic and molecular features, differing from advanced metastatic tumors.
Advanced NB aligns with a multistep tumor development model, whereas stage 4S NB may arise from impaired differentiation or a single additional mutation.

Conclusions:

Distinct genetic aberrations correlate with neuroblastoma clinical stages and metastatic potential.
Stage 4S neuroblastoma represents a biologically distinct entity requiring tailored understanding and potentially different therapeutic strategies.

Related Experiment Videos